Amy Bigbee is Assistant Director of Practice Advisory Services at McKesson. The Practice Advisory Services team has experience working with a variety of specialties, including oncology, rheumatology, gastroenterology, ophthalmology, neurology, and others. The team provides reimbursement consulting and analytics tailored to meet the specific needs of practices, and their full range of solutions help to improve patient outcomes and reduce costs while complying with increased reporting requirements.
Tommy Pourmahram is Vice President of Multisource Products and Analytics at McKesson. Tommy’s team is dedicated to increasing access while lowering overall cost of care by helping providers and biopharmaceutical companies alike incorporate this exciting new class of biosimilar therapies into treatment regimens across the U.S. The McKesson Biosimilar Resource Hub is a comprehensive resource page for biosimilar 101 resources, a list of biosimilar therapies available through McKesson, industry trends and advice from biosimilar experts.
Omar Hafez is an expert in the area of biosimilar therapies, having led efforts to increase access while lowering overall cost of care. His work focused on helping providers and biopharmaceutical companies, alike, incorporate this exciting new class of therapies into treatment regimens across the U.S.
As the government has implemented step therapy in Medicare Advantage plans, and some commercial payers are preferring biosimilars, clarity around biosimilars and their reimbursement channels is paramount for providers and biosimilar pharmaceutical companies alike.